View Regeneron Pharmaceuticals, Inc. REGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Regeneron Pharmaceuticals reported strong ... and marketed numerous fully human monoclonal antibodies utilizing their VelociSuite platform technology. This platform allows for the rapid generation ...

Trap and Regeneron’s antibody drug platform VelociSuite gave birth to multiple popular drugs, including Sanofi’s top-selling product, IL-4/13 inhibitor Dupixent. In 2022, Regeneron recorded ...

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies ...

Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite ® technologies, such as VelocImmune, which uses unique genetically humanized ...

PE: Can you discuss Regeneron’s VelociSuite Technologies and how that has bolstered ongoing research in hematologic malignancies? Rodriguez-Lorenc: We have different kinds of platforms, including the ...

Regeneron Pharmaceuticals ... accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized ...

Regeneron Pharmaceuticals ... accelerates the traditional drug development process through its proprietary VelociSuite t ...